Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
AstraZeneca
Boehringer Ingelheim
Moodys
Merck

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for L-Alanine

See Plans and Pricing

« Back to Dashboard

Drug Development Status for L-Alanine: Patents, clinical trial progress, indications

L-Alanine is an investigational drug.

There have been 7 clinical trials for L-Alanine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2013.

The most common disease conditions in clinical trials are Myocardial Ischemia, Coronary Disease, and Coronary Artery Disease. The leading clinical trial sponsors are University of Arkansas, Emory University, and Targeted Medical Pharma.

There are two hundred and twenty-three US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for L-Alanine
TitleSponsorPhase
Impact of Perioperative Treatment With Intravenous Glutamine on Myocardial Protection in Cardiac Surgery Patients With Aortic StenosisYonsei UniversityN/A
Mechanistic Approach to Preventing Atrophy and Restoring Function in Older AdultsNational Institute on Aging (NIA)Phase 2
Mechanistic Approach to Preventing Atrophy and Restoring Function in Older AdultsOregon Health and Science UniversityPhase 2

See all L-Alanine clinical trials

Clinical Trial Summary for L-Alanine

Top disease conditions for L-Alanine
Top clinical trial sponsors for L-Alanine

See all L-Alanine clinical trials

US Patents for L-Alanine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
L-Alanine   Start Trial Synthetic polymeric drugs Ceskoslovenska Akademie Ved (Praha, CS) Carlton Medical Products Limited (London, GB2)   Start Trial
L-Alanine   Start Trial Substituted amino acid compounds Adir et Compagnie (Courbevoie, FR)   Start Trial
L-Alanine   Start Trial Solid phase peptide synthesis using a polyacrylic support in aqueous solution Societe d'Expansion Scientifque Expansia (FR)   Start Trial
L-Alanine   Start Trial Cyclic anticoagulant peptides Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH)   Start Trial
L-Alanine   Start Trial Azoxy compounds Kowa Company Ltd. (Aichi, JP)   Start Trial
L-Alanine   Start Trial Use of glutamine to reduce rate of pathogenic microorganism infection Brigham and Women's Hospital (Boston, MA)   Start Trial
L-Alanine   Start Trial Amino nitrile intermediate for the preparation of alanine diacetic acid The Dow Chemical Company (Midland, MI)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for L-Alanine

Drugname Country Document Number Estimated Expiration Related US Patent
L-Alanine Austria 60991 2005-01-04   Start Trial
L-Alanine Australia 5183386 2005-01-04   Start Trial
L-Alanine Australia 589587 2005-01-04   Start Trial
L-Alanine Canada 1305053 2005-01-04   Start Trial
L-Alanine Germany 3581921 2005-01-04   Start Trial
L-Alanine Denmark 164485 2005-01-04   Start Trial
L-Alanine Denmark 3386 2005-01-04   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Dow
Express Scripts
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.